Edgen Stock·Sep 25 2025, 14:44戻る
戻る
Keros Therapeutics Restructures, Focuses on Early-Stage DMD Asset
Edgen Stock·Sep 25 2025, 14:44
[1] Keros Therapeutics: A Potential Dart Throw (NASDAQ:KROS) | Seeking Alpha (https://seekingalpha.com/article/4825839-kero ...)[2] Keros Therapeutics: A Potential Dart Throw (NASDAQ:KROS) (https://seekingalpha.com/article/4636000-kero ...)[3] Hertz to issue $375 million in exchangeable senior notes due 2030 - Investing.com (https://vertexaisearch.cloud.google.com/groun ...)